Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
Crossref DOI link: https://doi.org/10.1007/s40120-016-0061-5
Published Online: 2017-01-16
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Andrew
Pike, James
Edwards, Michael R.
Petrillo, Jennifer
Waller, John
Jones, Eddie
Funding for this research was provided by:
Biogen